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The Board
Ms. M.Windle
(Chairman)
Northern Area Health Board
Mr.T. Hourigan
Mid-Western Health Board
Ms. B. Clarke
South Western Area Board
Mr. R. Dooley
South Eastern Health Board
Mr. D. Moloney
Department of Health & Children
Mr. P. Healy
Southern Health Board
Mr.T. McGuinn
Department of Health & Children
The members 
of the Board 
as at 
31st December 2002
Mr.T. Kelly
North Western Health Board
Mr. P. Marron
Midland Health Board
Mr. S. Mannion
(Vice Chairman)
Western Health Board
Ms. Maureen Windle (Chief Executive Officer, Northern Area Health Board) was elected
Chairman of the Board, in December 2002, succeeding Mr. Donal O Shea, who retired from
the Board in November. Also in December Mr. Seamus Mannion (Regional Manager, Western
Health Board) was elected Vice Chairman of the Board succeeding Mr. Tom O’ Dwyer who had
retired from the Board in 2002. Mr. Patrick Burke replaced Mr. Tom Flood, who retired as
Chief Officer of the Board in May 2002.
Mr. Bernard Carey (Department of Health & Children) was elected to membership of the
Board in May 2002. Mr. Richard Dooley (South Eastern Health Board) and Mr. Pat Healy
(Southern Health Board) were designated by their respective Chief Executive Officers to be
members of the Board in November 2002. These three members replaced Mr. Eamon
Corcoran, Mr. Dermot Halpin and Mr. Tom O’ Dwyer.
Mr. Kevin McCarthy (East Coast Area Health Board) and Mr. Donal O Shea (Eastern Regional
Health Authority) resigned in September and November respectively and at year-end no new
members had been appointed.
The Board extends a warm welcome to its new members and records its thanks and appreciation
to those former members who, in the course of the year resigned their membership.
Mr. G. Day
North Eastern Health Board
Mr. P. Burke
Chief Officer
Mr. B. Carey
Department of Health & Children
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Constitution of the Board
The General Medical Services (Payments) Board is a body corporate with perpetual succession and a
common seal constituted by Order of the Minister for Health under Section 11 of the Health Act, 1970.
The Board consists of fourteen members comprising:
(a) (i) one officer of each Health Board designated by the Chief Executive Officer of the Health Board and
(ii) one officer of each Area Health Board established by Section 14 of the Eastern Regional Health
Authority Act, 1999, designated by the Area Chief Executive of the Area Health Board and 
(b) three other persons appointed by the members referred to in (a) (i) and (ii).
Functions of the Board
It is the duty of the Board to perform on behalf of the Health Boards the following functions in relation
to the provision of services by General Practitioners, Pharmacists, Dentists and Optometrists/
Ophthalmologists under Sections 58, 59 and 67 (i) of the Health Act 1970:
(a) the calculation of payments to be made for such services;
(b) the making of such payments;
(c) the verification of the accuracy and reasonableness of claims in relation to such services; 
(d) the compilation of statistics and other information in relation to such services.
Ms. M.Windle Mr. P. Burke
Mr. S. Mannion Mr.T. Kelly Mr.T. Hourigan Mr. R. Dooley Mr. P. Healy
Mr. D. Moloney Mr. B. Carey Mr.T. McGuinnMr. G. Day Ms. B. Clarke
Mr. P. Marron
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Almost all payments for services provided in the
community by General Practitioners, Community
Pharmacies, Dentists and Optometrists/
Ophthalmologists are made by the Board.
Payments in the Year 2002 were in excess of
€1,270m. Estimated payments by the Board for
2003 are €1,460m.
Claim data is processed and payments are made by
the Board under the following Schemes/Payment
Arrangements:
General Medical Services (GMS)
Persons who are unable without undue hardship
to arrange general practitioner medical and
surgical services for themselves and their
dependants and all persons aged 70 years and over
receive a free general medical service.
Drugs, medicines and appliances supplied under
the Scheme are provided through retail
pharmacies. In most cases the Doctor gives a
completed prescription form to a person, who
takes it to any pharmacy that has an agreement
with a Health Board to dispense GMS
prescription forms. In rural areas the Doctor may
dispense for those persons who opt to have their
medicines dispensed by him/her. All GMS claims
are processed and paid by the Board. 
Drugs Payment Scheme (DPS)
Under the Drugs Payment Scheme persons who
are ordinarily resident in the State and who do not
have a current medical card can benefit - an
individual or family has now to pay no more than
€65 in a calendar month for approved drugs,
medicines and appliances for themselves or their
families. In order to benefit under this Scheme a
person must register themselves and their
dependants with their local Health Board. Items
currently reimbursable under the Drugs Payment
Scheme are those listed in the GMS Code Book.
Other items which were reimbursable under the
DCS and Refund of Drugs Schemes continue, in
certain circumstances, to be reimbursable under
the Drugs Payment Scheme. DPS claims are
processed and paid by the Board. 
Long Term Illness Scheme (LTI)
On approval by Health Boards persons who suffer
from one or more of a schedule of illnesses are
entitled to obtain, without charge, irrespective of
income, necessary drugs/medicines and/or
appliances under the LTI Scheme. All LTI claims
are processed and paid by the Board. 
Dental Treatment Services Scheme (DTSS)
Under the Dental Treatment Services Scheme
GMS eligible adults have access to a range of
treatments and clinical procedures comprised of
Routine Treatments and Full Upper and Lower
Dentures. Routine Treatments are now available
for all eligible persons. Dentists may also
prescribe a range of medicines to eligible persons.
All claims under the DTSS are processed and paid
by the Board. 
European Economic Area (EEA)
Residents from one of the other states of the
European Economic Area, with established
eligibility, who require emergency general
practitioner services while on a temporary visit to
the State are entitled to receive from a General
Practitioner a GMS prescription form for
necessary medication and to have such medication
dispensed in a Pharmacy that has entered into an
agreement with a Health Board within the State.
Students, posted workers and their dependants are
entitled to full services on presentation of a valid
Form E128. EEA claims are paid by the Board. 
Community Based Services – Payment Arrangements 
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High Tech Drugs (HTD)
Arrangements are in place for the supply and
dispensing of High Tech medicines through
Community Pharmacies. Such medicines are
generally only prescribed or initiated in hospital
and would include items such as anti-rejection
drugs for transplant patients or medicines used in
conjunction with chemotherapy or growth
hormones. The medicines are purchased by the
Health Boards and supplied through Community
Pharmacies for which Pharmacists are paid a
patient care fee: the cost of the medicines and
patient care fees are paid by the Board. 
Primary Childhood Immunisation Scheme
A National Primary Childhood Immunisation
Scheme provides for immunisation of the total
child population with the aim of eliminating, as
far as possible, such conditions as Diphtheria,
Polio, Measles, Mumps, Rubella and more
recently Meningococcal C Meningitis. Payments
under this Scheme to Doctors in the Midland,
Mid-Western, Southern and Western Health
Boards are made by the Board. 
Health (Amendment) Act 1996
Under the Health (Amendment) Act 1996 certain
health services are made available without charge
to persons who have contracted Hepatitis C
directly or indirectly from the use of Human
Immunoglobulin - Anti D or the receipt within
the State of another blood product or blood
transfusion. General Practitioner services,
pharmaceutical services, dental services and
optometric/ophthalmic services provided under
the Act are paid for by the Board.
Methadone Treatment Scheme
Methadone is prescribed and dispensed by
Doctors and Pharmacists for approved clients
under the Methadone Treatment Scheme -
capitation fees payable to participating Doctors
and Community Pharmacists and claims by
pharmacies for the ingredient cost of the
Methadone dispensed and the associated
dispensing fees are processed and paid by the
Board.
Health Board Community Ophthalmic
Services Scheme (HBCOSS)
Under the Health Board Community Ophthalmic
Services Scheme, adult medical card holders 
and their dependants are entitled, free of 
charge, to eye examinations and necessary
spectacles/appliances. Claims by Optometrists/
Ophthalmologists are paid by the Board. Claims
for spectacles provided under the Children’s
Scheme are also paid by the Board.
Immunisations for certain GMS Eligible
Persons
Agreement was reached between the Department
of Health & Children and the Irish Medical
Organisation on fee rates to be applied to certain
immunisations for GMS eligible persons. The
immunisations encompassed by the agreement
are: Pneumococcal, Influenza, Hepatitis B and the
combined Pneumococcal/Influenza. The Board
facilitated claiming for any of these immunisations
by extending the range of codes for ‘Special Items
of Service’.
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As I commence my tenure as Chairman of the
General Medical Services (Payments) Board it is
my pleasure to join with the members of the Board
to present the Annual Report for the year 2002, the
Board’s 29th Annual Report.
I would like to take this opportunity to record our
appreciation for the work, stewardship and
endeavours of our outgoing Chairman, Mr. Donal
O Shea. With the exception of a brief period
(1988/89) Donal was Chairman of the Board from
1980 until his retirement in November 2002. I join
with my fellow Board members in saluting the way
in which he has given leadership to the Board in
dealing with complex issues that have presented in
the delivery of health services over the years. 
The commitment and dedication of Mr. Tom Flood
the former Chief Officer of the General Medical
Services (Payments) Board, who retired from the
Board’s service in May 2002, after 30 years service,
is sincerely appreciated and acknowledged by the
Board. Tom was responsible for executing and
contributed to formulation of the Board’s policies.
He can be credited with building the infrastructure
foundations from which the Board’s operations are
now delivered. Tom can also be credited with the
recruitment, training and retention of a highly
skilled and dedicated staff that continue to serve the
Board diligently.
The Board confirmed my appointment as
Chairman at its meeting in December 2002 and I
would like to express my appreciation to all my
Board colleagues and to the Chief Officer and staff
of the General Medical Services (Payments) Board
for their support and advice since I became
Chairman.
The core business of the Board is the processing of
claims, the making of payments and the provision
of information. Our achievements over the past
year have been very significant particularly in the
way that we have continued to implement an
eCommerce infrastructure in order to address our
day-to-day business operations by using state of the
art technology and also in the active way the Board
has continued to promote the agenda for
eGovernment. 
The General Medical Services (Payments) Board
strives to provide a modern, economic, efficient and
effective service, on behalf of Health Boards, to
primary care contractors, through developing: 
- An electronic business environment capable of secure
efficient transaction and information processing in
an area of expanding demand;
- The use of intelligent business agents to support
management in the identification and analysis of
current and projected trends and reporting on these
trends on a business level, but primarily from the
perspective of quality patient care.
This Annual Report for 2002 reflects, as in previous
years, the many and varied Schemes and payment
systems which generated the workload of the Board
in the year under review – while this workload was
significantly greater than in any previous year, the
Board’s management and staff responded to these
new challenges with determination and
commitment to provide the best possible service to
our clients.
The Board is accountable to the Public Accounts
Committee of the Oireachtas for its expenditure, in
accordance with its statutory role and
responsibilities and is subject to annual external
audit by the Comptroller & Auditor General. The
Department of Health & Children (DoH&C)
retains a policy oversight of our operations. 
We are committed to the highest standards of
corporate governance and as part of an ongoing
review of the governance arrangements we have
taken a number of actions to strengthen the risk
management structures and control processes in
operation. 
Chairman’s Statement
Ms. M. Windle (Chairman)
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During the year we continued to work closely with
Health Boards and the Health Board Executive
(HeBE) in relation to the management and
reconciliation of the various databases between our
respective organisations. This matter arose
following the implementation of the granting of
medical cards without means tests to persons aged
70 years and over, when it became apparent that the
number of people who qualified under this
agreement was significantly higher than that
originally estimated.
We have for some time now being pursuing an
agenda for change in relation to the mechanisms
and systems used to register and maintain the
database of persons eligible for health services. We
are continuing to work with the Regional Health
Boards and the Health Board Executive in order to
manage the implementation of these changes.
In promoting its wider eCommerce agenda
specifically by supporting the development of
telematic links with primary care contractors the
Board is currently involved in two national
Information Technology Projects:
 the Central Client Eligibility Index (CCEI) and 
 the Community Pharmacy Reimbursement
project. 
These projects are central to the Business and
Information Systems Strategy adopted by the Board
in 1999 and I am pleased to report that they are well
advanced. 
The primary driver for the Central Client Eligibility
Index project is to enable better control and
management of client data and file synchronisation
between this Board and Health Board systems.
The implementation plan provides for a working
pilot system to be deployed in the North Eastern
Health Board in 2003, continuing, when the system
is fully developed, with a full rollout to all Health
Boards to take place during 2004.
The establishment of the Health Board Executive
(HeBE) has provided an excellent platform for
communication and conjoint action between this
Board and Health Boards and I welcome this
development.
During the course of the year the Board’s
relationship with our colleagues in the Health
Boards was maintained and developed over a wide
range of mutual issues and primarily from the
perspective of supporting primary care contractors
in ensuring the delivery of quality patient care. 
The Board’s executive has in the course of the year
continued the practice of meeting with stakeholders
to discuss issues of mutual interest and where
necessary to endeavour to resolve difficulties when
they arise. The co-operation and goodwill shown by
these groups is very much appreciated. 
Our Board would like to acknowledge General
Practitioners, Community Pharmacists, Dentists,
Optometrists/Ophthalmologists and their staffs for
their enduring dedication to the delivery of Primary
Health Care Services to their communities. We
recognise the importance of good communication
with our customers and we have re-engineered our
website to provide user-friendly information and
support to our entire client base. 
The staff of Health Boards especially those who deal
directly with service providers and service users and
who interface regularly with the staff of the Board
are again very deserving of a special word of
appreciation. I would also like to thank the officers
from the Health Board Functional Teams, Finance,
Human Relations and Information Systems, who
have worked with the Board’s executive on many
different committees addressing strategic issues. I
understand that the officers who have been involved
in these endeavours and contributed to the Board’s
operations have found the process to be enriching
for both the staff of this Board and Health Boards.
I would also thank the Minister for Health &
Children and the officers of the Department who
have worked closely with the Board and the Board’s
executive. 
To the Chief Officer and his staff, who continue to
provide a very efficient and professional service in a
dynamic and complex business environment, I say a
special thank you. 
My thanks and appreciation to my fellow Board
Members. Members who regularly attend meetings
of the Board and who participate in so many other
ways in the work of the Board will help me
enormously to discharge my role as Chairman. 
Ms. Maureen Windle
Chairman
10 General Medical Services Report 2002
The GMS (Payments) Board administers the
payments and compiles the statistics in relation 
to the community-based services provided by
5,186 primary care professionals on behalf 
of Health Boards. The Schemes administered
include: 
 General Medical Services (GMS)
 Drugs Payment (DP)
 Long Term Illness (LTI)
 Dental Treatment Services (DTS)
 European Economic Area (EEA)
 High Tech Drugs (HTD)
 Primary Childhood Immunisation 
 Health (Amendment) Act, 1996
 Methadone Treatment 
 Health Board Community Ophthalmic
Services (HBCOS)
To support the regional Health Boards in the
delivery of these primary health care services the
Board has installed and maintains, a range 
of Information Technology systems and
procedures. In technology architecture and
processing terms the Board could be positioned 
at a level with the mid to high-end building
societies and banks. With approximately 
43 million business transactions per annum with
a transaction value level approaching €1.5 billion
the scale of business activity places the
organisation in this sector also.
Payments in the year 2002 were in excess 
of €1,270m, significantly up (23.8%) on
payments of €1,026m made in the year 2001.
The following table sets out in summary form the
overall increase in terms of the number of items
which the Board has reimbursed during the year
and the associated costs.
Summary of trends and patterns - 
2002 over 2001
%
Description 2002 2001 Increase
Persons Registered 2.58m 2.44m 6%
% of registered 
population who 
availed of services 77% 88% -
No. of Items 43m 39m 10%
Payments
Doctors €282.07m €213.98m 32%
Pharmacies €817.55m €674.80m 21%
Dentists €45.72m €41.65m 10%
Optometrists €13.94m €9.81m 42%
Wholesalers HTD €80.31m €61.23m 31%
Estimated payments by the Board for 2003, based
on the information currently available, will be
approximately €1.45 billion. The Board received
notification of its allocation for 2003 in
December 2002 and this allocation must be
managed within the parameters outlined. This
will present significant challenges in the coming
year particularly when viewed from the
perspective of the Board’s relatively narrow remit
i.e. that of a processing and payments board. 
The Board plans to prepare three-year
projections of Scheme Expenditures so as to
enable an informed view to be made of known
trends over the medium term. Such an exercise
will be valuable in assessing for example the
potential impact of an ageing population on the
cost of the GMS Scheme following its extension
to all over-seventies, the impact of increased
prescribing rates and so on. 
Although the GMS (Payments) Board is held
accountable for its expenditure, in practice the
level of expenditure in any given year is subject to
many variables outside our direct control. Most,
Review and Outlook
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if not all, of the Schemes administered are
demand led. Once eligibility is confirmed the
Board must manage reimbursement both in
respect of services provided by the primary care
contractors and also in respect of basic capitation
fees and allowances, which flow from patient
registration. In addition to this the Board has no
control over the range of medicinal products,
which are approved and become reimbursable
under the various Schemes.
Governance and Accountability
Overview of Schemes
The GMS (Payments) Board administers
payments on a range of Schemes relating to the
treatment of eligible persons in a primary or
community care setting and covers, inter alia,
payments in respect of medical card, drug cost
subsidisation, long term illness, high tech drugs,
dental treatment and ophthalmic services.
The Schemes are at the centre of the primary care
infrastructure in the health system and a major
part of total expenditure within the Schemes is
demand led. The population eligible for services
under the Schemes also significantly influences
this expenditure. Expenditure by the Board has
more than doubled over the past five years and at
current levels accounts for nearly 17% of total
non-capital public health spending. 
The total expenditure arising from the Schemes
administered by the Board in 2002 was €1.27bn
and expected to increase to approximately
€1.45bn in 2003. This increase is due to a
number of factors – higher population coverage,
expansion of services provided within existing
Schemes, increased fee rates to contractors,
provision and reimbursement of more expensive
drugs/medicines and inflationary cost factors. 
Governance
Governance arrangements for state agencies,
such as the GMS (Payments) Board, are
influenced by the Code of Practice for Governance of
State Bodies published by the Department of
Finance, which sets out the key elements of
corporate governance.
The GMS (Payments) Board is committed to the
highest standards of corporate governance and in
2002 has commenced a comprehensive review of
its overall governance arrangements and has
taken a number of actions to strengthen the risk
management and control processes in operation. 
This comprehensive review includes –
 consideration of the Code of Practice for
Governance of State Bodies, with a view to
ensuring that the existing governance
arrangements are strengthened to meet 
best possible standards
 the appointment of a number of new
Committees to assist the Board in
discharging its functions.
These new committees (whose purpose is to
support the effective operation of the Board)
include an Audit Committee and a Finance
Committee. 
The Audit Committee will monitor the adequacy
and effectiveness of the risk management and
internal control framework in operation in the
Board, approve the Audit Strategy and Plan,
review the actual work of the Internal Audit
function and maintain a liaison relationship with
the External Auditors. 
The role of the Finance Committee is to support
the Chief Officer in relation to all aspects of
financial management of the Board’s activities, to
assist in the preparation of a Service Plan and
Annual Budget and generally to provide support
in areas of operational risk, regulatory
compliance and business ethics. 
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Pharmacy Claims and Payments
At year-end almost 75% of Pharmacists were
submitting approximately 2.4 million claim items
electronically each month and in the majority of
cases were qualifying for payment within 14
working days. 
The Comptroller and Auditor General
(Amendment) Act, 1993 provides for the Audit of
the Board’s Accounts by the Comptroller and
Auditor General. Over the past number of years
the Audit has highlighted uncertainty regarding
the validity of a proportion (Circa 8%) of claims
submitted for payment. The volume of pharmacy
claims, which are presented for payment with
incomplete patient data, has been a matter of
serious concern to the Board over many years. A
number of initiatives over the years, including the
replacement of medical cards with laminated
plastic cards, have not succeeded in eliminating
this problem. 
In December 2002, the Department of Health &
Children advised the Board that the Government
had decided that the practice of reimbursing
Pharmacists for claims with incomplete eligibility
documentation should cease and that the practice
of issuing Advance Payments should also cease.
(Advance Payments were issued to Pharmacists
because the data was captured manually and the
lead-time for claim reimbursement was
approximately 6 weeks. As a result of the
introduction of electronic claim submission this
has now been reduced to 14 working days). The
Board moved immediately to implement the
Government decisions. Following discussions
and on the basis of agreement with the Irish
Pharmaceutical Union (IPU), that all
stakeholders would work jointly to implement
initiatives aimed at resolving the issues
underpinning these incomplete claims, the Board
and the Department of Health & Children
agreed to suspend for a short period the
immediate implementation of the decision that
could effect payments, pending a speedy
resolution of the issues involved.
The programme of work to resolve these issues,
which includes the participation of the Irish
Pharmaceutical Union (IPU), includes the
following:
(1) Synchronisation of all patient databases
(Health Board, GMS (Payments) Board and
individual Community Pharmacy)
(2) Definition and adoption of protocols
regarding emergency situations where a
Pharmacist must dispense on an urgent basis 
(3) Implementation of a national protocol
regarding Management and Control of
Client Registration for all Schemes.
In relation to all of these issues work is
progressing well and it is planned that they will be
resolved during 2003.
General Practitioners
In the course of the year the Chief Officer met
with representatives of the Irish Medical
Organisation (IMO) on a number of occasions to
discuss operational issues. These meetings
provided a forum for agreement regarding how
the operation of the Schemes could become more
transparent and effective.
It was agreed that through the use of technology
General Practitioners could be afforded greater
access to the Board’s databases and that the
current reporting arrangements could be
enhanced to provide greater clarity and
transparency.
It was also agreed that this forum would examine
how the current business processes regarding
client registration could be streamlined and how
the proposed implementation of an electronic
swipe card, with more comprehensive client and
contractor data, could assist in this regard.
At year-end more than 200 General Practitioners
have a facility for inputting Special Type
Consultation/Special Service claims directly into
the Board’s claims processing systems using the
Review and Outlook continued
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web based system developed and implemented by
the Board. This web based facility is also being
enhanced to allow General Practitioners access
the lists of patients on their panels and it will
provide the facility to download these lists for
General Practitioners to input into their own
local Practice Management Systems. We are
aware of the potential and opportunities that can
be exploited through these media and will
continue to support the development of health
care applications conscious of the requirement
for security, privacy and confidentiality.
During the year the Board fully implemented the
agreement that the Department of Health &
Children had reached with the Irish Medical
Organisation in 2001. This agreement in addition
to dealing with the introduction of universal
eligibility to persons aged 70 years and over, also
included a significant range of additional
contractual changes, including:
 Primary Childhood Immunisation Scheme 
 Practice Nurses and Secretaries
 Practice Nurse & Practice Secretary
Establishment Grant
 Discretionary Medical Cards
 Asylum Seekers 
 Medical Indemnity 
 Former District Medical Officers – Increases
to Guaranteed Salary 
 Training Grants
 Temporary Residents/Non Rota Patients/
E111/E128
 Out-of-Hours Review
During the year the Board continued to work
closely with Health Boards and the Health Board
Executive (HeBE) in relation to managing the
incidence of excess registrations on the GMS
database. This issue arose following the decision
to grant medical cards without means tests to
persons aged 70 years and over, when it became
apparent that the number of people who qualified
under this agreement was significantly higher
than that originally forecast. Work is continuing
in this area and it is planned that any excess
payments that have been made will be recouped
once the associated legal and contractual issues
are addressed.
Dental Treatment Services Scheme
(DTSS)
In March 2002, following protracted
negotiations, the Board implemented the new
validation procedures. This resulted in an
application for an interlocutory injunction, which
was not granted, against the Board on the
grounds that the validation procedures had not
been agreed or accepted by the Irish Dental
Association (IDA). The Board has on a number of
occasions advised Dentists regarding the
operational procedures associated with claim
reimbursement and is also seeking to work with
the IDA and contracting Dentists in order to use
technology where appropriate to make the
systems more effective. A pilot project, initiated
by the IDA, regarding claim submission has been
well received by the Board. The Board is
confident that this initiative can be a base for
future progress.
Review of Reimbursable Non Drug Items
The Board’s Non Drug Review Group conducts
an Annual Review of the list of Non Drug Items
that are reimbursable under the GMS Scheme. 
This Group comprises of Health Board
personnel with expertise in the various
disciplines, representatives of the Department of
Health & Children and the GMS (Payments)
Board. Prior to the review process executive
officers of the Board meet with individual
manufacturers and representatives of the industry
on matters relevant to the Annual Review. The
Board, through its executive and aided by external
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advisors, is informed in relation to best practice
and EU Directives affecting this area of the
Board’s business.
The products added and price changes
implemented in 2002 relate to the following
categories – Clinical Nutritional Products,
Diagnostics, Dressings, Ostomy Appliances,
Urinary Appliances, Syringes/Needles and
Lancets. 
Taking cognisance of the difficulties in predicting
the prescribing patterns or quantities required of
Non Drug Items in the year ahead it is estimated
that the cost in this area of the GMS Scheme will
increase by more than 14.36% i.e. from €39.7m
to €45.4m approx. 
As part of its brief this Review Group will also
conduct a review of dressings. It is planned that
the result of this part of the Review will be the
publication of guidelines that will incorporate the
criteria with which Manufacturers must comply
when applying to have dressings reimbursable
under the GMS Scheme. Because of the complex
nature of the applications for the newer
generation of dressings submitted to date it is
expected that there will be some difficulty 
in categorising these products and it is planned
that this phase of the review will be completed
during 2003. 
Indicative Drug Targets (IDT)
During the year the Board established a Review
Group to examine the current drug target
methodology. This Review will consider whether
using age and gender in the calculations is
sufficient, or if the medical needs of persons on
Doctors’ panels should be more closely
integrated into the calculations. The Group met
on a number of occasions and is currently
examining the principles/guidelines of the
Indicative Drug Target Scheme. It is planned that
a final report of this group will be presented to
the Board later in 2003.
Administration
In 2002, General Administration costs were
€13.71m. 
Of this the principal cost headings were – 
 €0.30m was the cost of providing laminated
plastic cards for the Drugs Payment Scheme
which was introduced in July 1999 
 €2.71m was attributable to ongoing
computer systems development,
maintenance and software licence costs
 €0.28m was expended on Health Board
stationery (prescription forms, claim 
forms etc.) 
 €1.9m for other stationery supplies 
 €0.42m was expended on postal and
telephone charges. 
Salaries, wages and other staff costs totalled
€4.75m i.e. less than 0.4% of the Board’s total
expenditure. 
Information Technology and Business
Strategy Development
In the Business Statement & Information Systems
Strategy, adopted in 1999, proposals are set out
for the use of state of the art technology to address
the Board’s day-to-day business operations. 
Because of the fact that the Personal Public
Service (PPS) Number represents a key part of
the eGovernment strategy, the PPS number is
central to the development of the Board’s
Information Technology infrastructure. For this
reason the Board believes that the PPS number is
an essential piece of data to be collected on
patient registrations under all Schemes. The
Board however recognises, that because of the
fact that individuals might not always have their
PPS number to hand when registering, there is a
need for exceptional arrangements to be in place
to allow for emergency registration without the
PPS number.
Review and Outlook continued
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The Board is currently involved in two national
Information Technology Projects (1) the Central
Client Eligibility Index (CCEI) and (2) the
Community Pharmacy Reimbursement project.
These projects are central to Board’s strategy and
are well advanced. 
CCEI Project
This project provides for the implementation of a
national Central Index and supporting enhanced
schemes administration systems in Health Boards
to enable control and management of client data
and file synchronisation between the Board and
Health Board systems.
The Board has implemented a technical solution.
Pilot trials were held in the North Eastern Health
Board in early 2002 and the business process issues
encountered have now been resolved and
agreement has been reached on an implementation
plan for the project. The project plan provides for
a further period of pilot implementation in the
North Eastern Health Board and following
completion of this a full rollout to all Health
Boards will commence in the autumn of 2003, with
full implementation during 2004.
Community Pharmacy Reimbursement
Project Description
This project provides for claims to be validated
directly against the Board’s Central Index, by
means of swipe cards issued to eligible persons,
plus electronic claims from pharmacies via secure
electronic messaging. The project to develop the
interface between the Board and a number of
pharmacies, using software components
integrated into the pharmacy systems supplied by
the main pharmacy system vendors in Ireland, is
well underway. A technical solution is currently
being tested and pilot trials are ongoing in a
number of pharmacies nationwide. 
In view of the operational efficiencies and
additional controls provided to the health services
through electronic reimbursement and electronic
patient identification the Department of Health
& Children has agreed with the Irish
Pharmaceutical Union to provide partial grant
aid to pharmacies who deploy the new
technology. 
European Commission - Information
Society Technologies (IST) 5th Framework
Since January 2000 the Board has been involved
in a Research & Development Project funded
(under the 5th Framework Programme) by the
Information Society Technology, European
Commission. The project entitled ‘Professionals
and Citizens Network Integrated Care’ (PICNIC)
will finalise early in 2003.
The aim of PICNIC is to prepare regional
healthcare providers to implement the next
generation of secure, user-friendly healthcare
networks with the Board specifically involved
from the perspective of clinical messaging and the
reimbursement service. The Board plans to
develop, as part of the PICNIC project, common
components and provide these components to
pharmacy system vendors. This initiative will
support the system vendors in providing patient
identification functionality to Pharmacists to
allow them to verify eligibility for services at the
point of contact and allow them forward claims
for reimbursement directly to the GMS
(Payments) Board.
Raven House Lease
The Board has a break option and rent review in
the lease for Raven House, which can be
exercised in December 2004. Since the Board
moved into Raven House in 1975, the business
and associated Information Technology
infrastructure has grown significantly. In order to
ensure that a proper business continuation
strategy is in place, the Board is addressing all
aspects of its office accommodation, including the
IT facility. To this end a Steering Group has been
established to advise and make recommendations
to the Board.
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 Payments in the Year were in excess of €1,270.88m.
 Claim data is processed and payments are made by the Board under the following Schemes:
 General Medical Services (GMS);
 Drugs Payment (DP); 
 Long Term Illness (LTI);
 Dental Treatment Services (DTS);
 European Economic Area (EEA);
 High Tech Drugs (HTD);
 Primary Childhood Immunisation;
 Health (Amendment) Act 1996;
 Methadone Treatment;
 Health Board Community Ophthalmic Services (HBCOS).
 At year end there were more than 2.58m persons registered as being eligible to benefit under the
General Medical Services, Drugs Payment, Long Term Illness, Dental Treatment and Health
Board Community Ophthalmic Services Schemes.
 More than 77% of eligible GMS persons availed of GP, Pharmaceutical, Dental or Ophthalmic
services provided by more than 5,186 Doctors, Pharmacists, Dentists and Optometrists/
Ophthalmologists.
 More than 40.2m prescription items were paid for by the Board - an increase of over 4.2m items
on 2001.
 Fees and allowances paid to Doctors totalled €282.07m.
 Payments to Pharmacies totalled €817.55m:
 GMS €550.89m;
 DP €192.37m;
 LTI €61.64m;
 EEA €1.54m;
 Patient Care Fees under the HTD Scheme €4.32m;
 The Health (Amendment) Act 1996, Methadone Treatment Scheme and DTS prescriptions
€6.79m.
 Payments to Dentists under the DTS totalled €45.72m.
 Payments to Optometrists/Ophthalmologists under the HBCOS totalled €13.94m.
 Payments to Wholesalers under the HTD Scheme totalled €80.31m.
 Administration costs in the accounting period of 2002 were €13.71m.
 Claims processed are in respect of services provided in the community and availed of by almost
64% of the population.
Summary Statement of Activity During the Year 
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The Year 2002
Doctors Fees €201.99m
Allowances €80.08m
Pharmacists Fees and Mark-Up €211.83m 
Drugs and Medicines €601.40m 
Dentists €45.72m
High Tech Drugs Scheme 
Payment to Wholesalers €80.31m
Patient Care Fees paid to Pharmacists €4.32m 
Optometrists €13.94m
Administration €13.71m 
Investment in General 
Practice Development €17.58m 
Total of Payments for the year
€1,270.88m
 Allowances paid to Doctors include an amount of €5.90m paid as superannuation to Retired District
Medical Officers and their dependants.
 Fees to Doctors include an amount of €5.27m in respect of the Primary Childhood Immunisation
Scheme, €0.20m in respect of the Health (Amendment) Act 1996, €3.40m in respect of the
Methadone Treatment Scheme.
 Payments to Pharmacists include an amount of €1.01m in respect of drugs/medicines dispensed
under the Health (Amendment) Act 1996, an amount of €5.33m in respect of the cost of Methadone
dispensed under the Methadone Treatment Scheme and an amount of €0.45m in respect of DTS
prescriptions.
 The corresponding figures for 2001 are – 
Total of Payments €1,026m.
Doctors’ Fees €145.46m and Doctors’ Allowances €68.52m.
Pharmacists’ Fees and Mark-Up €176.94m, Drugs and Medicines €493.98m.
Payments to Dentists under the DTS Scheme were €41.65m.
Payments to Optometrists €9.81m.
Investment in General Practice Development was €11.60m.
High Tech Drugs Scheme – Payment to Wholesalers €61.23m, Patient Care Fees €3.88m.
Administration €12.71m.
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2,134 Doctors 1,349 Dentists 454 Optometrists1,249 Pharmacists
Number of Agreements
The number of agreements between Health Boards and General Practitioners for the provision of
services to GMS persons reflects the policy position agreed between the Department of Health &
Children and the Irish Medical Organisation on entry to the GMS. In December 2002 there were
2,134 such agreements. There were 150 GPs who do not hold GMS agreements and who were
registered as providing services under the Primary Childhood Immunisation Scheme, the Health
(Amendment) Act 1996 and the Methadone Treatment Scheme at year end.
Number of Agreements as at 31st December 2002
Health Board Doctors Pharmacists Dentists Optometrists
East Coast Area 213 117 88 38
South West Area 276 163 197 56
Northern Area 230 129 138 51
Midland 115 70 74 36
Mid-Western 197 129 96 37
North Eastern 159 106 145 49
North Western 131 69 76 21
South Eastern 207 137 139 46
Southern 359 199 281 61
Western 247 130 115 59
National 2,134 1,249 1,349 454
Corresponding figures for 2001 1,863 1,203 1,315 437
213 Dentists who are employees of Health Boards and who provide services under the Dental Treatment Services Scheme are included above.
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Persons Eligible for Services
Eastern Regional Boards 344,270 451,122 44,303
Midland 70,657 75,088 4,192
Mid-Western 99,095 127,749 6,475
North Eastern 104,445 123,705 5,965
North Western 96,924 62,347 4,439
South Eastern 138,600 135,873 8,209
Southern 176,425 224,618 13,305
Western 138,329 118,893 5,857
National 1,168,745 1,319,395 92,745
% of Population 29.84% 34% 2.34%
Corresponding figures for 2001 1,199,454 1,156,836 87,988
Health Board GMS DP LTI
GMS 1,168,745 LTI 92,745
Persons who are unable without undue hardship to arrange General Practitioner medical and surgical
services plus dental and optometric services for themselves and their dependants are provided with
such services free of charge under the GMS Scheme. An eligible person is entitled to select a Doctor
of his/her choice, from among those Doctors who have entered into agreements with Health Boards.
Drugs, medicines and appliances prescribed by participating Doctors for their GMS patients are
provided through Community Pharmacies. Dental and ophthalmic services are provided by Dentists
and Optometrists/Ophthalmologists who have contracted with Health Boards. GMS prescription
forms may be dispensed in any Pharmacy that has an agreement with a Health Board to dispense
GMS prescription forms. In rural areas, where a Doctor has a centre of practice three miles or more
from the nearest retail Pharmacy participating in the Scheme, the Doctor dispenses for those persons
served from the centre who opt to have their medicines dispensed by him/her. The number of eligible
GMS persons at year end included 54,918 persons who were entitled and had opted to have their
medicines dispensed by their GPs.
Under the terms of the Drugs Payment Scheme persons who do not have a medical card may apply
for a Drugs Payment Scheme card on an individual or on a family unit basis. Prescribed medicines,
which are reimbursable under the GMS, costing in excess of a specified amount per month, currently
€65 per family, is claimed by the pharmacy and is paid by the Board.
On approval by Health Boards persons who suffer from one or more of a schedule of illnesses are
entitled to obtain, without charge, irrespective of income, necessary drugs/medicines and/or
appliances under the LTI Scheme. The Board makes payments on behalf of Health Boards for LTI
claims submitted by Pharmacies.
GMS - General Medical Services Scheme. DP - Drugs Payment Scheme. LTI - Long Term Illness Scheme.
Number of Eligible Persons as at 31st December 2002
DP 1,319,395
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Payments to General Practitioners are categorised as fees and/or allowances. For the majority of GPs
who operate under the 1989 agreement the principle fee item is the capitation per person which is
weighted for gender, age and distance from Doctor’s centre of practice - capitation fees totalled
€148,955,173 in 2002 - an increase of €52,052,269 over 2001. Fees totalling €1,975,702 were paid to
21 GPs who continue to provide services under the Fee-Per-Item of service agreements.
Apart from ‘Out-of-Hours’ fees and fees for a range of special services the cost of services provided in
normal hours by GPs for GMS persons, including the prescribing of necessary medicines, is
encompassed by the capitation fee. All GMS persons can avail of full GP services and in many cases they
can benefit from specialist clinics provided by GPs for issues such as Women’s Health, Family Planning
and Asthma.
In addition to a capitation fee an outside normal hours fee is payable for non routine consultations when
an eligible GMS person is seen by their GP or another GP acting on his/her behalf from 5pm in the
evening to 9am on the following morning (Monday to Friday) and all hours on Saturdays, Sundays and
Bank Holidays. The number of ‘Out-of-Hours’ claims increased to 481,407 in 2002 compared with
464,321 in 2001 - and the cost of such claims increased to €20,349,451 from €18,259,061 in 2001.
Special fees are payable for a range of 18 services such as excisions, suturing, vaccinations,
catheterization, family planning etc. (refer to page 34 for full list of special items) - the most frequent
claimed special service in 2002 was Influenza Vaccination (272,525) followed by Excisions (54,583) and
Nebuliser treatments (37,977) - there was a total of more than 486,635 special services provided in 2002
- special fees totalling €14,161,099 were paid in 2002.
Annual and Study Leave together with locum, nursing and secretarial support plus other practice
support payments account for most of the €80,080,605 allowances paid in the year. The total paid in
2001 was €68,514,898.
The total of payments to Doctors in the Midland, Mid-Western, Southern and Western Health Boards includes payments of
€5,273,494 under the Primary Childhood Immunisation Scheme; €198,882 to Doctors who provided services under the Health
(Amendment) Act 1996 and €3,397,257 under the Methadone Treatment Scheme.
For details of Fees and Allowances payable refer to pages 34 to 35.
Health Board 2002
Total of Payments to Doctors by Health Board
East Coast Area 21,366,704
South West Area 32,458,244
Northern Area 26,365,956
Midland 18,186,989
Mid-Western 24,552,584
North Eastern 24,924,272
North Western 21,557,531
South Eastern 33,405,581
Southern 43,975,700
Western 35,274,772
National €282,068,333
Corresponding figure for 2001 €213,981,671
Payments to Doctors
Fees €201.99m Allowances €80.08m
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Corresponding
figures for 2001 170,699 172,286 449,358 464,321
Health Board Fee-Per-Item Special Type Special Service Out-of-Hours
East Coast Area 2,517 10,976 38,683 29,638
South West Area 37,814 12,510 47,261 38,959
Northern Area 27,617 12,924 43,709 32,590
Midland - 16,617 29,834 32,419
Mid-Western 22,351 17,122 37,480 35,832
North Eastern - 9,513 40,049 11,313
North Western - 13,427 39,935 40,077
South Eastern 10,070 17,402 67,001 71,839
Southern 35,234 32,402 75,662 109,499
Western - 30,841 67,020 79,241
National 135,603 173,734 486,634 481,407
A majority of Doctors are paid an annual capitation fee for each eligible person - the rate of payment is
determined by the age/gender of the person and distance between each person’s residence and the centre
of practice of their Doctor-of-Choice.
A minority of Doctors (21) who have continued to provide services under the Fee-Per-Item of Service
agreement are paid a fee for each Doctor/Patient contact.
STC - A Special Type Consultation fee is payable when a GMS eligible person is unable to contact their
registered Doctor and is seen as an emergency case by another. 
General Practitioners qualify for payment of ‘special fees’ for the special items of service separately
identified under the Capitation agreement and the Fee-Per-Item agreement.
Number of Claims in each Health Board
Volume of Claims by Doctors
Special Type 173,734 
Fee-Per-Item 135,603
Special Service 486,634 
Out-of-Hours 481,407
National - Number of Claims - 2002
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East Coast Area 38,128,149 18,761,248 6,784,589 51,218
South Western Area 68,966,768 33,133,932 10,926,980 80,258
Northern Area 59,221,599 28,825,897 9,342,430 53,108
Midland 36,543,065 10,478,602 3,164,842 76,991
Mid-Western 49,335,197 17,123,915 4,566,647 146,587
North Eastern 49,379,131 15,425,553 5,133,004 124,514
North Western 36,739,674 7,079,455 3,351,207 243,123
South Eastern 65,046,017 17,907,568 6,439,967 167,648
Southern 86,705,248 29,077,107 7,724,317 336,311
Western 60,827,690 14,552,891 4,201,858 263,787
National €550,892,538 €192,366,168 €61,635,841 €1,543,545
*EEA - Payment to Pharmacies to cover the cost of GMS prescriptions dispensed for residents from the European Economic Area.
Pharmacies were also paid in respect of the drugs/medicines dispensed under: Health (Amendment) Act 1996 - €1,017,727;
Methadone Treatment Scheme - €5,326,470; DTS Scheme - €450,933 and Patient Care Fees totalling €4,323,703 under the 
High Tech Drugs Scheme. (Payments to Wholesalers under the High Tech Drugs Scheme amounted to €80,306,977).
For details of Fees refer to page 36.
Health Board GMS DP LTI *EEA
€ € € €
Total of Payments to Pharmacies by Health Board
Corresponding 
figures for 2001 €434,019,532 €177,616,777 €52,080,599 €1,410,112
A GMS person who is provided with a properly completed GMS prescription form by his/her GP can
choose to have such prescription forms dispensed in any of the Pharmacies who have entered into
agreements with Health Boards for the provision of services under Section 59 of the Health Act, 1970.
In 2002 there were 11.6m prescription forms containing 29.5m prescription items dispensed at a cost
of over €537,874,666 i.e. an average cost of €18.24 per dispensed item. More than 77% of all eligible
GMS persons were prescribed for in the year. The average cost of medicines per GMS person in 2002
was €457.93.
Payments made to Pharmacies under the GMS and DTS Schemes are inclusive of the ingredient cost
of medicines, dispensing fees and VAT.
Under DP, LTI and EEA Schemes Pharmacies are reimbursed the ingredient cost of items dispensed;
dispensing fees and VAT; a markup of up to 50% on the ingredient cost of items dispensed is also paid.
The cost of the High Tech Drugs Scheme was €84.6m - at year end there were 18,364 persons
registered under this Scheme - Patient Care Fees totalled €4.32m and payments for drugs and
medicines totalled €80.31m.
In the year the Board processed claims valued at €193.4m on drugs acting on the ‘cardiovascular
system’ (GMS €121.6m, DP €63.3m and LTI €8.5m). The second highest cost category was drugs
acting on the ‘nervous system’ €166.24m (GMS €111.12m, DP €45.7m, LTI €9.42m). The third
highest amount paid was for drugs acting on the alimentary tract and metabolism system €150.3m
(GMS €84.55m, DP €48.27m, LTI €17.48m).
Payments to Pharmacies
GMS €550.89m DP €192.37m LTI €61.64m EEA €1.54m
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Health Board GMS DP LTI EEA HTD *Other
Corresponding 
figures for 2001 25,658,179 8,985,466 1,157,876 74,788 110,201 243,241
East Coast Area 2,031,733 894,892 131,951 2,824 9,141 4,520
South West Area 3,760,952 1,453,636 223,159 4,312 16,800 6,837
Northern Area 3,110,620 1,298,763 202,647 2,734 14,115 7,034
Midland 1,944,495 529,388 66,717 3,646 6,949 4,520
Mid-Western 2,719,803 816,929 101,734 7,211 8,933 6,837
North Eastern 2,655,382 773,143 111,968 5,497 11,100 7,034
North Western 1,898,016 330,660 65,634 11,829 9,142 4,502
South Eastern 3,496,753 924,404 132,284 8,940 13,035 9,225
Southern 4,814,955 1,386,183 165,319 16,021 16,278 12,485
Western 3,066,990 654,937 78,697 12,507 12,647 7,361
National 29,499,699 9,062,935 1,280,110 75,521 118,140 194,737
* This group includes 16,541 claim items in respect of the Health (Amendment) Act 1996; 131,304 items under the Methadone
Treatment Scheme and 46,892 prescription items under the DTS Scheme.
GMS - General Medical Services Scheme. DP - Drugs Payment Scheme.
LTI - Long Term Illness Scheme. EEA - European Economic Area. HTD - High Tech Drugs Scheme.
Other - Methadone Treatment Scheme, Health (Amendment) Act 1996 and Dental Treatment Services Scheme.
Volume of Claims by Pharmacies
GMS 29.5m
DP 9.06m
LTI  1.28m
EEA 0.07m
HTD 0.12m
Other 0.19m
National - Number of Items - 2002
GMS prescription forms processed for payment in the year totalled 11.6m - the total of prescribed items was
more than 29.5m - these accounted for approximately 73% of all items paid for by the Board in 2002.
Approximately 42% of forms contained a single item; more than 22% contained 2 items - the average
number of items per form was 2.55 (2001 – 2.44).
GMS dispensed items paid for by the Board in 2002 increased by more than 3,978,000 - the increase in
the number of DP items was more than 77,000 - the overall increase in the number of pharmacy claims
processed by the Board in the year was more than 2.6m.
Number of Items in each Health Board
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Eastern Regional Boards €12,177,076
Midland €2,544,377
Mid-Western €3,882,221
North Eastern €3,813,325
North Western €3,212,523
South Eastern €5,410,888
Southern €8,982,288
Western €5,649,743
National €45,672,441
Dentists were also paid a total of €45,080 in 2002 in respect of treatments under the Health (Amendment) Act 1996.
For details of Fees refer to page 37.
Dentists were paid a total of €45,672,441 in 2002, in respect of treatments provided for more than
207,885 GMS persons under the DTS Scheme.
The following treatments were available to all eligible GMS persons.
ROUTINE - Routine treatments are categorised as either ‘Above the Line’ or ‘Below the Line’: 
‘Above the Line’ treatments are uncomplicated procedures viz. Amalgam; Extractions; 
‘Below the Line’ treatments are advanced procedures viz. Protracted Periodontal;
Prosthetics.
‘Below the Line’ treatments - prior Health Board approval for a specific course of treatment under this
category is required. Full denture treatment is available, with prior Health Board approval, to all
edentulous GMS persons over 16 years. 
Health Board 2002
Payments to Dentists in each Health Board
Corresponding figure for 2001 €41,613,269
Payments to Dentists
Above the line €29.17m Below the line €16.49m
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Volume of Claims by Dentists
Above the Line 893,205 
Below the Line 109,578
National - Volume of Treatments - 2002
Corresponding
figures for 2001 876,109 104,819 186,900
Eastern Regional Boards 247,200 26,835 55,325
Midland 46,431 7,126 11,659
Mid-Western 76,220 8,430 18,240
North Eastern 74,873 10,282 18,821
North Western 69,350 5,372 15,400
South Eastern 100,966 14,315 25,917
Southern 172,140 23,487 39,311
Western 106,025 13,731 25,433
National 893,205 109,578 210,106
Health Board
+Below the
Line
+Above the
Line
No. of 
persons treated
under DTS
Volume of Treatments by Dentists in each Health Board
ROUTINE - Routine treatments are categorised as either ‘Above the Line’ or ‘Below the Line’:
‘Above the Line’ (ATL) treatments are uncomplicated procedures;
‘Below the Line’ (BTL) treatments are advanced procedures.
+ The most frequently used ATL service was Amalgam Restoration which was used by 85,092 patients followed by Oral Examination.
In the BTL category the most frequently used service was Prosthetics followed by Radiographs and Protracted Periodontal.
Corresponding figure for 2001 €9,810,369
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Eastern Regional Boards €3,561,974
Midland €957,152
Mid-Western €1,313,686
North Eastern €996,363
North Western €1,012,749
South Eastern €2,112,227
Southern €2,582,299
Western €1,403,704
National €13,940,154
For details of Fees refer to page 38.
Under the Health Board Community Ophthalmic Services Scheme Optometric/Ophthalmic services
are provided to adult medical card holders, which includes free eye examinations and necessary
spectacles/appliances.
Payments in respect of spectacles provided under the Childrens Scheme are also made by the Board on
behalf of the majority of Health Boards.
In the 12 month period to the end of December 2002 claims were received on behalf of 154,501 eligible
persons for 397,578 treatments costing €13,940,154. 
Eye examinations by Optometrists/Ophthalmologists totalled 145,357; complete spectacles (distance,
reading and bi-focals) provided under the Scheme totalled 199,189. The balance of treatments included
replacement lenses and frames, tinted lenses, prisms and contact lenses. 
Health Board 2002
Payments to Optometrists/Ophthalmologists in each Health Board
Payments to Optometrists/Ophthalmologists
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Volume of Treatments by Optometrists/
Ophthalmologists
Appliances 252,221
Eye Exams 145,357
National - Volume of Treatments - 2002
Eastern Regional Boards 41,054 57,378 98,432 41,856
Midland 8,860 19,325 28,185 9,437
Mid-Western 11,277 26,484 37,761 13,273
North Eastern 10,744 18,066 28,810 11,331
North Western 10,704 19,807 30,511 11,287
South Eastern 20,786 40,547 61,333 21,857
Southern 27,871 43,703 71,574 30,121
Western 14,061 26,911 40,972 14,970
National 145,357 252,221 397,578 154,132
Health Board Eye Exams Appliances Volume No. of
of Treatments persons treated
Volume of Treatments by Optometrists/Ophthalmologists 
in each Health Board
Corresponding 
figures for 2001 106,129 199,795 305,924 111,613
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Cost per Eligible Person
Health Board
GMS €679.08
LTI €677.37
DP €936.54
DTS €217.38
HBCOS €85.83
National – 2002
Cost per Eligible Person in each Health Board
Eastern Boards 211.15 463.89 675.04 624.82 1,007.74 220.16 85.67
Midland 230.27 503.76 734.03 789.36 911.85 218.23 85.49
Mid-Western 220.21 481.50 701.71 726.30 922.23 212.84 87.83
North Eastern 224.36 458.53 682.89 868.42 861.95 202.61 85.93
North Western 211.56 373.35 584.91 777.43 960.54 208.60 83.29
South Eastern 229.30 460.90 690.20 824.88 836.55 208.77 88.11
Southern 226.98 481.67 708.65 564.04 881.14 228.49 85.50
Western 231.12 427.63 658.75 736.04 935.13 221.14 83.85
National €221.15 €457.93 €679.08 €677.37 €936.54 €217.38 €85.83
Corresponding 
figures for 2001 €169.46 €371.08 €540.54 €608.16 €890.10 €222.65 €86.33
The Doctor cost above does not include superannuation paid to retired DMOs.
Medical and pharmaceutical services delivered to GMS persons increased in cost by €138.54 per
eligible person - the cost of medical services per person increased by more than 23% as also did the cost
per person of pharmaceutical services.
GMS LTI DP DTS HBCOS
Net Cost Per Per 
Doctor Pharmacy Total Pharmacy Per Person Adult 
Cost Cost Cost Cost Claimant Treated Treated
€ € € € € € €
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Major Therapeutic Classification of Drugs, Medicines 
and Appliances - General Medical Services Scheme
A Alimentary Tract and Metabolism 84.55 15.3
B Blood and Blood Forming Organs 18.80 3.4
C Cardiovascular System 121.59 22.1
D Dermatologicals 11.57 2.1
G Genito Urinary System and Sex Hormones 23.51 4.3 
H Systemic Hormonal Preps. excl. Sex Hormones 5.53 1.0 
J General Anti-infectives for Systemic Use 26.86 4.9 
L Antineoplastic and Immunomodulating Agents 4.21 0.8 
M Musculo-Skeletal System 38.02 6.9
N Nervous System 111.12 20.2
P Antiparasitic Products 0.77 0.1 
R Respiratory System 52.00 9.5
S Sensory Organs 11.04 2.0
V Clinical Nutritional Products 19.96 3.6
Ostomy Requisites 6.84 1.2
Urinary Requisites 1.86 0.3
Diagnostic Products 8.33 1.5
Needles/Syringes/Lancets 1.47 0.3
Dressings 1.26 0.2
Miscellaneous 1.61 0.3 
Total €550.90m 100%
Major Therapeutic Classification €m %
C - 22.1%
N - 20.2%
A - 15.3%
R - 9.5%
V - 7.4%
Other - 25.5%
National - 2002
30 General Medical Services Report 2002
Major Therapeutic Classification of Drugs,
Medicines and Appliances - Drugs Payment Scheme
Major Therapeutic Classification €m %
C - 22.0%
A - 16.8%
N - 15.9%
R - 12.6%
V - 4.0%
Other - 28.7%
National - 2002
Note: The above costs are inclusive of the monthly payment of €65 payable to the Pharmacy by an individual or family.
A Alimentary Tract and Metabolism 48.27 16.8
B Blood and Blood Forming Organs 6.25 2.2
C Cardiovascular System 63.30 22.0
D Dermatologicals 11.10 3.9
G Genito Urinary System and Sex Hormones 21.39 7.4
H Systemic Hormonal Preps. excl. Sex Hormones 2.29 0.8
J General Anti-infectives for Systemic Use 16.19 5.6
L Antineoplastic and Immunomodulating Agents 3.37 1.2
M Musculo-Skeletal System 18.25 6.4
N Nervous System 45.70 15.9
P Antiparasitic Products 0.35 0.1
R Respiratory System 36.29 12.6
S Sensory Organs 3.32 1.1
V Ostomy Requisites 3.67 1.3
Urinary Requisites 1.11 0.4
Clinical Nutritional Products 4.92 1.7
Dressings 0.55 0.2
Diagnostic Products 0.58 0.2
Needles/Syringes/Lancets 0.10 0.0
Miscellaneous 0.49 0.2
Total €287.49m 100%
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Major Therapeutic Classification of Drugs, Medicines 
and Appliances - Long Term Illness Scheme
Major Therapeutic Classification €m %
A - 28.4%
C - 13.8%
V - 35.2%
Other - 7.3%
N - 15.3%
National - 2002
A Alimentary Tract and Metabolism 17.48 28.4
B Blood and Blood Forming Organs 0.56 0.9
C Cardiovascular System 8.52 13.8
D Dermatologicals 0.12 0.2
G Genito Urinary System and Sex Hormones 0.44 0.7
H Systemic Hormonal Preps. excl. Sex Hormones 0.56 0.9
J General Anti-infectives for Systemic Use 1.80 2.9
L Antineoplastic and Immunomodulating Agents 0.07 0.1
M Musculo-Skeletal System 0.51 0.8
N Nervous System 9.42 15.3
P Antiparasitic Products 0.00 0.0
R Respiratory System 0.41 0.7
S Sensory Organs 0.10 0.1
V Diagnostic Products 13.58 22.1
Clinical Nutritional Products 4.36 7.2
Needles/Syringes/Lancets/Swabs 2.11 3.4
Nutritional/Ancillary Devices 0.49 0.8
Urinary Requisites 0.52 0.8
Ostomy Requisites 0.15 0.2
Dressings 0.13 0.2
Miscellaneous 0.31 0.5
Total €61.64m 100%
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Summary of Statistical Information relating to the GMS
Scheme for each of the five years 1998-2002
Number of Eligible Persons
in December 1,168,745 1,199,454 1,148,055 1,164,187 1,183,554
Doctors (000’s) (000’s) (000’s) (000’s) (000’s)
Total Payments €271,939 €203,863 €165,975 €151,292 €156,108
Doctors’ Payment per Person €221.15 €169.46 €138.43 €123.18 €124.18
Pharmacies (000’s) (000’s) (000’s) (000’s) (000’s)
Total Cost of Prescriptions €537,874 €422,464 €328,348 €281,699 €248,988
Ingredient Cost €423,269 €329,497 €262,881 €223,209 €194,652
Dispensing Fee €104,827 €85,413 €59,325 €52,843 €49,204
VAT €9,778 €7,554 €6,142 €5,647 €5,132
Number of Forms 11,551 10,454 9,737 9,631 9,475
Number of Items 29,500 25,521 22,882 21,679 20,696
Cost per Form €46.57 €40.41 €33.72 €29.24 €26.28
Cost per Item €18.24 €16.55 €14.35 €12.99 €12.02
Ingredient Cost per Item €14.35 €12.91 €11.49 €10.30 €9.41
Items per Form 2.55 2.44 2.35 2.25 2.18
(000’s) (000’s) (000’s) (000’s) (000’s)
Total Cost of Stock Orders €13,018 €11,555 €10,455 €9,452 €8,963
Ingredient Cost €10,059 €8,945 €8,072 €7,282 €6,900
Pharmacy Fees €2,515 €2,222 €2,019 €1,820 €1,726
VAT €444 €388 €364 €350 €337
(000’s) (000’s) (000’s) (000’s) (000’s)
Overall Cost of Medicines €550,892 €434,019 €338,803 €291,151 €257,951
Pharmacy Payment per Person €457.93 €371.08 €292.61 €246.39 €213.82
Overall Payments €822,831 €637,882 €504,778 €442,443 €414,059
Overall Payment per Person €679.08 €540.54 €431.04 €369.57 €338.00
2002 2001 2000 1999 1998
Doctors’ payment per person is exclusive of superannuation paid to retired DMOs.
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Summary of Statistical Information relating to the LTI Scheme
for each of the five years 1998-2002 and the DP Scheme for the
years 2000-2002
LTI Scheme
Number of Eligible Persons in
December 92,745 87,988 82,619 76,848 71,440
Average Number of Claimants 31,422 30,165 27,382 26,885 25,712
(000’s) (000’s) (000’s) (000’s) (000’s)
Number of Items 1,280 1,157 988 877 834
Total Cost €61,636 €52,081 €41,736 €34,548 €29,507
Cost per Item €48.15 €44.98 €42.26 €39.39 €35.40
Cost per Claimant €1,961.55 €1,726.52 €1,524.24 €1,285.04 €1,147.61
Cost per Person €677.37 €608.16 €524.00 €465.84 €426.20
DP Scheme 
Number of Eligible Persons in
December 1,319,395 1,156,836 942,193
Average Number of Claimants 205,578 199,546 155,638
(000’s) (000’s) (000’s)
Number of Items 9,063 8,985 7,776
Gross Cost €287,489 €262,187 €212,087
Net Cost €192,366 €177,617 €140,598
Gross Cost per Item €31.72 €29.18 €27.27
Gross Cost per Claimant €1,398.44 €1,313.92 €1,362.70
Net Cost per Claimant €935.73 €890.10 €903.37
Net Cost per Person €145.80 €153.54 €175.74
2002 2001 2000 1999 1998
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Fees and Allowances under Capitation Agreement
Ages Male Female Male Female Male Female Male Female Male Female
€ € € € € € € € € €
Up to 3 Miles 3-5 Miles 5-7 Miles 7-10 Miles Over 10 Miles
Up to 4 62.78 61.31 65.95 64.51 70.63 69.21 75.29 73.88 81.07 79.61
5 - 15 37.65 38.05 38.99 39.38 40.90 41.36 42.79 43.22 45.16 45.53
16 - 44 47.25 75.43 48.97 77.13 51.49 79.65 53.99 81.73 57.02 85.19
45 - 64 91.48 100.23 95.57 104.33 101.64 110.37 107.61 116.37 115.04 123.76
65 - 69 96.22 107.00 107.62 118.42 124.56 135.34 141.19 151.98 161.87 172.69
70 and over 99.25 110.36 110.98 122.15 128.50 139.61 145.69 156.83 167.02 178.19
Out-of-Hours Payment
Surgery €36.22
Domiciliary
Up to 3 miles €36.22
3 - 5 miles €48.33
5 - 7 miles €54.42
7 - 10 miles €60.39
Over 10 miles €72.49
Additional Fee €28.29
*Special Items of Service
(i) to (ix) €22.65
(x) and (xi) €33.99
(xii) €56.66
(xiii) €39.27
(xiv) €62.86
(xv) and (xvi) €31.18
(xvii) €46.79
(xviii) €112.44
+Mileage
Temporary Residents
Surgery €36.22
Domiciliary
Up to 3 miles €36.22
3 - 5 miles €48.33
5 - 7 miles €54.42
7 - 10 miles €60.39
Over 10 miles €72.49
Rural Dispensing Fee €32.30
Fee for Second Medical Opinion €24.17
Practice Payments for Rural Areas
Rural Practice Allowance Per Annum €14,867.70
Practice Support
Allowance for Practice Secretary
up to a maximum Per Annum of €19,894.27
Allowance for Practice Nurse
up to a maximum Per Annum of €31,262.43
Contributions to Locum Expenses
(Subject to the conditions of the Agreement)
Annual Leave Up to a maximum of 
Sick Leave €1,261.19 per week
Study Leave Up to a maximum of 
Maternity Leave €180.17 per day
Contributions to 
Medical Indemnity Insurance
Calculation of contribution is related to GMS
panel numbers and net premium.
Asylum Seekers
A one off superannuable registration fee of
€139.32 per relevant patient will be paid to
Doctors in respect of each such patient on 
their GMS Scheme panels.
Capitation Fees as at 31st December 2002
* Special Items of Service.
(i) Excisions/Cryotherapy/
Diathermy of Skin Lesions.
(ii) Suturing of Cuts and
Lacerations.
(iii) Draining of Hydroceles.
(iv) Treatment and Plugging 
of Dental and Nasal
Haemorrhages.
(v) Recognised Vein Treatment.
(vi) ECG Tests and their
Interpretation.
(vii) Instruction in the fitting
of a Diaphragm.
(viii) Removal of Adherent
Foreign Bodies from the
Conjunctival Surface of
the Eye.
(ix) Removal of Lodged or
Impacted Foreign Bodies
from the Ear, Nose and
Throat.
(x) Nebuliser Treatment 
in the case of Acute
Asthmatic Attack.
(xi) Bladder Catheterization.
(xii) Attendance at case
conferences (in cases
where such are convened
by a DCC/MOH).
(xiii) Advice and Fitting 
of a Diaphragm.
(xiv) Counselling and 
Fitting of an IUCD.
(xv) Pneumococcal Vaccination.
(xvi) Influenza Vaccination.
(xvii) Pneumococcal/Influenza
Vaccination.
(xviii) Hepatitis B Vaccination.
Above rates inclusive of supplementary Out-of-Hours Fee.
The Capitation rate is €480.64 per annum for persons aged 70 years and over in the community issued
with a medical card for the first time regardless of income. A Capitation rate of €696.58 per annum will
apply to anyone aged 70 years and over in a private nursing home (approved by a Health Board) for any
continuous period of five weeks.
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Fees and Allowances under the Fee-Per-Item Agreement and 
Fees under the Immunisation Scheme, Health (Amendment) 
Act 1996 and Methadone Treatment Scheme
As at
Surgery Consultations 31st December 2002
Day Normal Hours €9.98
Late Outside Normal Hours other than (Night) €14.19
Night Midnight to 8.00 a.m. €28.07
Domiciliary Consultations
Day Normal Hours
Urban €14.73
Up to 3 miles €14.73
3-5 miles €19.28
5-7 miles €25.89
7-10 miles €32.46
Over 10 miles €40.59
Late Outside Normal Hours
Urban €19.28
Up to 3 miles €19.28
3-5 miles €24.92
5-7 miles €32.46
7-10 miles €43.12
Over 10 miles €50.58
Night Midnight to 8.00 a.m.
Urban €37.79
Up to 3 miles €37.79
3-5 miles €48.57
5-7 miles €61.44
7-10 miles €68.58
Over 10 miles €74.44
Emergency Fee/EEA Fee (Additional to Standard Fee) €10.91
Dispensing Fee €10.91
Rural Practitioner’s Allowance
Per Annum €6,433.58
Locum and Practice Expense Allowance
Per Annum €1,252.45
Sessional Rate - Homes for the Aged
Per 3 Hour Session €66.84
*Special Items of Service
(i) to (vii) €20.50
(viii) and (ix) €31.18
(x) €46.79
(xi) €112.44
Immunisation Fees
(i) Registration of child with a GP €32.70
(ii) Complete course of immunisation against
DPT/DT; Hib; Polio and MMR €108.94
(iii) 95% uptake bonus €52.48
Health (Amendment) Act 1996
Surgery Fee €31.22
Domiciliary Fee €41.16
Methadone Treatment Scheme
Patient Care Fee - up to a maximum per month of €105.81
* Special Items of Service.
(i) Excisions/Cryotherapy/
Diathermy of Skin
Lesions.
(ii) Suturing of Cuts and
Lacerations.
(iii) Draining of Hydroceles.
(iv) Treatment and Plugging
of Dental and Nasal
Haemorrhages.
(v) Recognised Vein
Treatment.
(vi) ECG Tests and their
Interpretation.
(vii) Instruction in the fitting
of a Diaphragm.
(viii) Pneumococcal
Vaccination.
(ix) Influenza Vaccination.
(x) Pneumococcal/Influenza
Vaccination.
(xi) Hepatitis B Vaccination.
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Scale of Fees Payable to Participating Pharmacists
as at 31st December 2002
High Tech Medicines Scheme
Reimbursement of ingredient cost plus
50% mark-up on ingredient cost plus
Standard Fee - 259c (Note 1)
20% mark-up on Incontinence Products and Dressings under DP Scheme
Extemporaneously dispensed preparations are reimbursed at current private prescription rates.
In the case of the Drugs Payment Scheme the Board makes payments to Pharmacies in respect of
authorised Patients whose monthly costs of prescribed drugs and medicines are in excess of the
specified monthly amount (currently €65) payable to the Pharmacy by an individual or family.
Note 1 The standard fee is an all inclusive fee which includes container and broken bulk allowance.
Patient Care Fee: €49.64 per month.
Methadone Treatment Scheme 
Patient Care Fee: Up to a Maximum of €49.59 per month.
DP/LTI/EEA Schemes and Health (Amendment) Act 1996
GMS Scheme c
Standard Fee-Per-Item (Note 1) 298.00
Extemporaneous Fee 570.02
Extemporaneous dispensing and compounding of
- Powders 1,710.05
- Ointments and Creams 1,140.03
Controlled Drugs 460.18
Non-Dispensing - Exercise of professional judgement 285.01
Phased Dispensing - each part of phased dispensing 285.01
Urgent/Late Dispensing
Additional fee for Urgent/Late dispensing other than between
midnight and 8.00 a.m. (Note 2) 793.62
Additional fee for Urgent/Late dispensing 
between midnight and 8.00 a.m. 1,639.14
Note 1 253.71c basic fee and 44.28c allowance for containers, obsolescence etc.
Note 2 Urgent fee prescriptions are those so specified by the prescriber and necessarily 
dispensed outside normal hours.
Late fee prescriptions are those which, though not marked urgent, are in exceptional 
circumstances necessarily dispensed outside normal hours by the Pharmacist, having 
regard to the person’s requirements.
Note 3 A Standard Fee-Per-Item is also payable on prescription forms issued by Dentists 
under the DTS Scheme.
Supplies to Dispensing Doctors
Pharmacies supplying Dispensing Doctors are reimbursed on the basis of the basic trade price 
with the addition of 25% on cost.
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Scale of Fees Payable under the 
Dental Treatment Services Scheme
Oral Examination 26.22
Prophylaxis 24.63
Restoration (Amalgam) 39.62
Restoration (Composite) 6 anterior teeth only 41.07 
Exodontics (Extraction under local anaesthetic) 31.30
Surgical Extraction - Maximum 3 units:
Fee payable for each 15 minute unit 27.87
Maximum 83.61
1st Stage Endodontic Treatment (Anterior teeth only) 45.35
Denture Repairs
1st Item of Repair 36.06
Each Subsequent Item 11.56
Maximum 59.18
Apicectomy/Amputation of Roots *Dentist 
Estimate
Endodontics (Anterior teeth only) *Dentist 
Estimate
Protracted Periodontal Treatment *Dentist 
Estimate
Radiographs 
1 Film 19.61
2 or more Films 29.65
Panoramic 32.82
Miscellaneous 
(e.g. Biopsy, Haemorrhage, Dressings etc.) 17.93
Prosthetics
Full Upper or Lower Denture 245.82
(Other than Edentulous Persons)
Partial Upper or Lower Acrylic Denture 180.30
Complete Upper or Lower Reline 98.40
Complete Upper and Lower Reline 163.80
Full Upper and Lower Denture (Edentulous Persons Only) 360.74
As at 31st December 2002
Treatment Type Routine
€
* Dentist Estimates are subject to agreement between a Dentist and a Health Board.
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Scale of Fees Payable under the Health Board Community
Ophthalmic Services Scheme
Eye Examination Ophthalmic Optician 19.75
Eye Examination Ophthalmologist/
Ophthalmic Medical Practitioner 22.41
Medical Eye Examination by 
Ophthalmologist 44.81
Eye Examination for Contact 
Lenses (Grant) 62.00(H)
Appliances
Single Vision Complete Appliances
Spectacles - Distance 43.09
Spectacles - Reading 43.09
Spectacles - Uncollected 30.23
Contact Lenses
Contact Lenses Standard 
or Disposable per pair (Grant) 66.96(H)
Single Vision Spectacles - 
with Glass Lenses Distance 113.50(H)
Single Vision Spectacles - 
with Glass Lenses Reading 113.50(H)
Single Vision Spectacles - 
with Plastic Lenses Distance 123.23(H)
Single Vision Spectacles - 
with Plastic Lenses Reading 123.23(H)
Single Vision Lenses to Own Frame
Replacement Distance Lens (1) 
to own frame 16.75
Replacement Distance Lenses (2) 
to own frame 33.49
Replacement Reading Lens (1) 
to own frame 16.75
Replacement Reading Lenses (2) 
to own frame 33.49
Other Items - Single Vision
Lenticular Lens (1 Surface) 11.74
Lenticular Lenses (2 Surfaces) 23.47
Lenticular Lenses (3 Surfaces) 35.21
Lenticular Lenses (4 Surfaces) 46.95
Tinted Lens (1) 7.59
Tinted Lenses (2) 15.16
Tinted Lenses (3) 22.75
Tinted Lenses (4) 30.32
Prism (1) 6.35
Prisms (2) 12.71
Prisms (3) 19.06
Prisms (4) 25.41
Prisms (5) 31.76
Prisms (6) 38.12
Prisms (7) 44.47
Prisms (8) 50.82
Dioptric powers higher than 8.00 
(1) Lens 6.15
Dioptric powers higher than 8.00 
(2) Lenses 12.29
Dioptric powers higher than 8.00 
(3) Lenses 18.44
Dioptric powers higher than 8.00 
(4) Lenses 24.59
Anti-Reflective Coating on 
Plastic Lens (1) 18.34(H)
Anti-Reflective Coating on 
Plastic Lenses (2) 36.68(H)
Dioptric powers higher than 6.00 
(Plastic) (1) Lens 15.37
Dioptric powers higher than 6.00 
(Plastic) (2) Lenses 30.73
Dioptric powers higher than 6.00 
(Plastic) (3) Lenses 46.10
Dioptric powers higher than 6.00
(Plastic) (4) Lenses 61.47
Plastic Lens (1) for children 
as prescribed 4.86
Plastic Lenses (2) for children 
as prescribed 9.73
Plastic Lens (1) Adult 4.86(H)
Plastic Lenses (2) Adult 9.73(H)
Bifocals
Spectacles Bifocal Complete 86.20
Fused Bifocal Spectacles 156.67(H)
Varifocals Spectacles - Glass 
or Plastic (Grant) 166.45(H)
Bifocal Lenses
Replacement Bifocal Lens (1) 
to own frame 38.33
Replacement Bifocal Lenses (2) 
to own frame 76.68
Varifocal Lens (1) (Grant) 43.22(H)
Varifocal Lenses (2) (Grant) 86.44(H)
Other Items - Bifocals
Sphere over 6.00 and up to 9.00 
extra charge (1) Lens 4.15
Sphere over 6.00 and up to 9.00 
extra charge (2) Lenses 8.30
Sphere over 9.00 extra charge 
(1) Lens 9.22
Sphere over 9.00 extra charge 
(2) Lenses 18.44
Tinted Lens (1) 8.36
Tinted Lenses (2) 16.70
Prism (1) 8.89
Prisms (2) 17.79
Repairs
Replacement Frame to own lenses 12.92
Replacement Front to own lenses 6.22
Replacement Side (1) to own frame 2.61
Replacement Side (2) to own frame 5.23
Complete New Frames 80.00(H)
Examinations € €
As at 31st December 2002
(H) Denotes fees payable in respect of services under the Health
(Amendment) Act 1996 only.
F i n a n c i a l
S t a t e m e n t s
f o r  ye a r  e n d e d
3 1 s t  D e c e m b e r
2 0 0 2
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The Board is required by the General Medical Services (Payments) Board (Establishment) Order, 1972
to prepare financial statements for each financial year which give a true and fair view of the state of the
affairs of the General Medical Services (Payments) Board and of the income and expenditure for that
period.
In preparing those statements, the Board is required to –
 select suitable accounting policies and apply them consistently 
 make judgements and estimates that are reasonable and prudent 
 disclose and explain any material departures from applicable accounting standards
 prepare the financial statements on a going concern basis unless it is inappropriate to presume that
the General Medical Services (Payments) Board will continue in existence.
The Board is responsible for keeping proper accounting records which disclose with reasonable
accuracy at any time the financial position of the General Medical Services (Payments) Board and which
enable it to ensure that the financial statements comply with the Order. It is also responsible for
safeguarding the assets of the General Medical Services (Payments) Board and hence for taking
reasonable steps for the prevention and detection of fraud and other irregularities.
On behalf of the Board
Maureen Windle, Chairman
Seamus Mannion, Vice Chairman
Statement of Board Members’ Responsibilities
for year ended 31st December 2002
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The Board was set up to make payments on behalf of
the Health Boards for general practitioner and
pharmaceutical services and dental treatment, which
the Health Boards provide to qualifying persons
under the Health Act 1970. The Board is reimbursed
its direct costs together with the administration costs
incurred in operating the payments service as set out
in Note 1 to the Accounts.
1. Basis of Accounting
The accounts have been prepared on an accruals basis
to reflect the costs of medicines and medical services
provided, and the administration costs incurred in the
year, and the matching income receivable to fund
these costs.
2. Doctors’ Fees and Allowances
Most services from doctors are provided under an
agreement concluded in 1989. Fees are mainly based
on capitation taking into account the age of the
patient and the distance from the surgery. 
3. Pharmaceutical Services
Payments to pharmacists are made under a service
agreement with Health Boards concluded in 1996.
This agreement covers medical card holders and
other schemes. With effect from 1996 claims have
been subject to third party confirmation.
4. Dental Treatment Services Scheme
Payments under this heading comprise amounts paid
to dentists operating as private practitioners in
respect of dental treatment provided for GMS
patients. The balance of such treatment is provided
directly by Health Boards.
5. Health Board Community 
Ophthalmic Services Scheme
Payments under this heading comprise amounts paid
from 1st July 1999 to optometrists and
ophthalmologists operating as private practitioners in
respect of examinations and appliances provided to
adult GMS patients. Services for children are
separately provided for by Health Boards.
6. Fixed Assets and Depreciation
Fixed Assets are stated at cost less accumulated
depreciation. Depreciation is provided for on all fixed
assets in order to write off the cost or valuation of the
assets over their anticipated useful lives. The
following rates of Depreciation have been applied on
a straight line basis.
Furniture, Fixtures & Fittings 10%
Information Technology 20%
Library 10%
Office Equipment 10%
7. Superannuation
Staff
A Superannuation Scheme operated by the Board is
in accordance with the Local Government
Superannuation Act, 1956 as amended. Benefits are
met from current income as they arise.
Superannuation deductions are retained by the Board
and included in Other Income. 
The Board operates a defined benefit Superannuation
Scheme for its employees. Superannuation
entitlements arising under the Scheme are paid out of
current income. Superannuation entitlements are
charged to the Income and Expenditure Account in
the year in which they become payable. No provision
is made in the financial statements in respect of future
benefits. Salaries and Wages are charged in the
financial statements net of employee superannuation
contributions. 
The above accounting treatment is not in accordance
with the requirements of Financial Reporting
Standard (FRS) 17
- which will require financial statements to reflect at
fair value the assets and liabilities arising from an
employer’s superannuation obligations
- and also any related funding and to recognise the
costs of providing superannuation benefits in the
accounting periods in which they are earned by
employees. 
As a transitional measure the Standard requires that
the present value of the Scheme’s liabilities be
disclosed in the notes to the 2001 financial
statements. In 2002 the Board was not in a position to
comply with the requirements of FRS 17 as it did not
obtain an actuarial valuation of the Scheme’s
liabilities. The Board has taken steps to ensure that it
will be able to comply with requirements of the
Standard in future years.
Doctors
A contribution of 10% of capitation payments is made
by the Board towards the superannuation of
participating doctors.
Accounting Policies
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2002 2001
Notes € €
Income
Recoupment from Department of Health &
Children and Health Boards 1 1,263,529,811 1,028,010,807
Rebate from Pharmaceutical Manufacturers 11,069,179 8,182,500
Other Income 2 425,972 384,448
Total Income 1,275,024,962 1,036,577,755
Expenditure
Administration 3 12,626,062 11,568,611
Doctors' Fees and Allowances 4 292,977,176 226,809,107
Pensions paid to former DMO's or Dependants 5 5,896,994 5,650,355
Pharmaceutical Services 6 900,894,605 739,021,743
Dental Treatment Services Scheme 7 45,749,245 42,064,281
Community Ophthalmic Services Scheme 8 14,466,661 9,741,291
Depreciation 10 763,863 685,415
Total Expenditure 1,273,374,606 1,035,540,803
Surplus/(Deficit) for year 1,650,356 1,036,952
Accumulated fund at 1st January 7,924,546 6,887,594 
Accumulated fund at 31st December 9,574,902 7,924,546
Notes 1-16 form part of these accounts
Income and Expenditure Account
for year ended 31st December 2002
2002 2001
Notes € € € €
Fixed Assets 10 2,064,706 2,119,385
Current Assets
Debtors 11 179,388,108 201,011,543
Stocks on Hand 12 7,485,129 5,780,095
Cash 218 218
186,873,455 206,791,856
Current Liabilities
Creditors 13 175,729,336 165,735,741
Bank 3,633,923 35,250,954
179,363,259 200,986,695
Net Current Assets 7,510,196 5,805,161
Net Assets 9,574,902 7,924,546
Represented by:
Accumulated Fund 9,574,902 7,924,546
Notes 1-16 form part of these accounts
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Balance Sheet as at 31st December 2002
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2002 2001
Note € €
Net Cash (Outflow)/Inflow
from Operating Activities (A) 32,326,215 (10,776,265)
Investing Activities
Purchase of Fixed Assets (709,184) (1,411,290)
(Decrease)/Increase in Cash
and Cash Equivalents (B) 31,617,031 (12,187,555)
(A) Analysis of Net Cash Inflow/(Outflow) from Operating Activities
2002 2001
€ €
Operating Surplus/(Deficit) 1,650,356 1,036,952
Depreciation Charges 763,863 685,415
(Increase)/Decrease in Debtors 21,623,435 (29,367,593)
(Increase)/Decrease in Stocks on Hand (1,705,034) (311,077)
Increase/(Decrease) in Creditors 9,993,595 17,180,038
Net Cash (Outflow)/Inflow
from Operating Activities 32,326,215 (10,776,265)
(B) Reconciliation of Increase/(Decrease) in cash and cash equivalents
as shown in the Balance Sheet
2002 2001 Change
€ € in Year
Bank (3,633,923) (35,250,954) 31,617,031
Cash in Hand 218 218 -
(3,633,705) (35,250,736) 31,617,031
Cash Flow Statement for year ended 
31st December 2002
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1. Recoupment from Department of Health & Children/Health Boards
The Health Boards fund the cost of the following Schemes administered by the Board: Drugs
Payment Scheme/Long Term Illness Scheme/Ophthalmic Services Scheme/Dental Treatment Services
Scheme/Childhood and GMS Immunisation Schemes/High Tech Drugs Scheme in respect of Non-
GMS patients and Methadone Scheme. Funding for the other schemes and services administered by
the Board, as well as the Boards’ administration costs, is provided by the Department of Health &
Children, on behalf of the Health Boards.The sums provided were:
2002 2001
€ €
Department of Health & Children 882,411,130 712,834,052
Health Boards 381,118,681 315,176,755
1,263,529,811 1,028,010,807
2. Other Income
2002 2001
€ €
Superannuation deductions GMS Staff 137,721 130,464
Superannuation deductions former District Medical
Officers and Dependants 19,974 22,440
Bank Interest and Sundries 268,277 231,544
425,972 384,448
3. Administration Expenditure
2002 2001
€ €
Staff Remuneration 4,653,652 4,067,758
Health Board Stationery 695,108 1,154,980
Computer Development 2,475,638 2,753,544
Premises Rent and Services 361,109 326,397
Office Supplies, Printing and Stationery 1,863,720 1,119,984
Bank Interest/Charges 25,475 51,574
Repairs and Maintenance (Equipment & Premises) 177,060 61,315
Postage and Telephone 403,413 401,732
Journals and Periodicals 352,528 94,973
Medical Training Courses - -
Legal Expenses 41,594 (317)
Audit Fee (7,066) 44,850
Bad Debts/Bad Debts Provision - -
Sundry Administration 1,583,831 1,491,821
12,626,062 11,568,611
Notes to the Financial Statements
General Medical Services Report 2002 49
4. Doctors’ Fees & Allowances 2002 2001
€ €
Fees
Capitation 148,955,173 96,340,270
Board's contribution to Doctors’ Superannuation Scheme 15,037,925 9,867,472
Special Type Consultations/Special Services 20,020,128 18,509,934
Out-of-Hours Fees 20,314,057 18,654,394
Fee-Per-Item Services 1,975,703 1,809,107
Dispensing Fees 1,663,491 2,161,778
Registration/Vaccination Fees 5,202,437 7,616,009
Methadone 2,436,251 1,953,775
Other Payments 180,109 202,045
215,785,274 157,114,784
Allowances
Leave (Annual/Sick/Study/Maternity) 7,663,785 7,469,401
Rural Practice Allowance 2,731,054 2,396,710
Practice Support 30,811,048 26,650,257
Rostering/Out-of-Hours Payments 6,514,614 6,527,020
Practice Equipment Payment 4,343,029 4,351,202
Locum & Practice Expenses 64,315 49,792
Medical Indemnity Insurance 1,614,281 1,539,159
Practice Support Grant 2,259,098 2,100,798
Drug Target Refunds 18,189,653 16,390,848
IMO Agreement:
Trainers/Trainees/One in One Rotas 1,225,139 634,869
75,416,016 68,110,056
Salaries
Salaries and Lump Sums to District Medical Officers 1,775,886 1,584,267
Total Doctors’ Fees & Allowances 292,977,176 226,809,107
5. Payments to Former District Medical Officers/Dependants
The Board made superannuation payments to 277 former District Medical Officers or their
dependants. These payments arose from the officer status with Health Boards of the Doctors and
their entitlement to hold General Practitioner contracts.
6. Pharmaceutical Services 2002 2001
€ €
Pharmacists’ GMS Claims 551,469,833 434,330,996
DPS/LTI Claims 258,209,800 233,844,038
European Economic Area Claims 1,542,543 1,482,672
High Tech Claims 83,144,142 63,791,527
Other Payments 1,040,368 883,161
Methadone Treatment Claims 5,487,919 4,689,349
900,894,605 739,021,743
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7. Dental Treatment Services Scheme
2002 2001
€ €
Emergency -136 8,144
Routine Dental Treatments 43,779,248 38,241,457
Denture Claims 1,951,682 3,792,070
Laboratory Claims - -
Other Payments 18,451 22,610
45,749,245 42,064,281
8. Community Ophthalmic Services Scheme
Fees 7,621,822 4,821,296
Appliances 6,844,839 4,919,995
14,466,661 9,741,291
9. Leasehold Premises
The Board's office premises are held on a 35 year lease dated 1st December 1974 from Calvinia Ltd.
The annual rent is €177,763, effective from 1st December 1999, with 5 year rent reviews. The
matter of securing a valuation of the Board's leasehold interest, with a view to its inclusion in the
Balance Sheet was examined. In the absence of any quantifiable benefit to the Board the cost of a
valuation could not be justified at this time.
10. Fixed Assets
Furniture Information Library Office Total
Fixtures Technology Equipment
Fittings
Cost € € € € €
Cost at 1.1.02 633,744 4,922,376 2,223 103,880 5,662,223
Additions 7,491 660,092 - 41,601 709,184
641,235 5,582,468 2,223 145,481 6,371,407
Depreciation
Accumulated Depreciation 
at 1.1.02 566,047 2,938,843 1,772 36,176 3,542,838
Depreciation for Year 
ended 31.12.02 15,845 733,356 114 14,548 763,863
581,892 3,672,199 1,886 50,724 4,306,701
Net Book Value at 31.12.02 59,343 1,910,269 337 94,757 2,064,706
Net Book Value at 31.12.01 67,697 1,983,533 451 67,704 2,119,385
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11. Debtors
2002 2001
€ €
Department of Health & Children and Health Boards 153,062,724 174,432,219
Rebates due from Pharmaceutical Manufacturers 5,740,473 4,694,533
Advance Payments to Pharmacists 20,429,208 21,357,631
Sundry Debtors 155,703 527,160
179,388,108 201,011,543
12. Stocks on Hand
Dispensing Doctors’ Stocks 1,788,465 1,652,344
High Tech Stocks 5,696,664 4,127,751
7,485,129 5,780,095
13. Creditors
Doctors’/Fees Salaries 61,470,452 60,392,083
Pharmacists’ Claims 105,112,006 95,908,939
Dental Treatment Services Scheme 2,950,957 3,094,676
Community Ophthalmic Services Scheme 861,427 849,748
Sundry Creditors 5,334,494 5,490,295
175,729,336 165,735,741
14. Indicative Drug Target Scheme - Cumulative Savings
The following table gives a breakdown of the cumulative savings made and the amounts paid under
the Indicative Drug Target Savings Scheme.
Savings Generated General
Health Board Practitioner Total
€ € €
Eastern Regional Boards 5,102,205 31,038,318 36,140,523
Midland 1,110,971 5,471,872 6,582,843
Mid-Western 1,619,815 7,495,336 9,115,151
North Eastern 1,610,669 8,858,660 10,469,329
North Western 2,196,609 13,522,216 15,718,825
South Eastern 2,850,942 12,853,007 15,703,949
Southern 2,746,742 15,015,624 17,762,366
Western 3,081,754 16,849,646 19,931,400
Research & Education Fund - - 1,937,969
National Savings 20,319,707 111,104,679 133,362,355
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14. Indicative Drug Target Scheme - Cumulative Savings (continued)
The following table gives a breakdown of the cumulative savings made and the amounts paid under
the Indicative Drug Target Savings Scheme.
Payments General
Health Board Practitioner Total
€ € €
Eastern Regional Boards 4,178,200 15,018,072 19,196,272
Midland 1,038,504 3,142,050 4,180,554
Mid-Western 1,559,134 4,938,209 6,497,343
North Eastern 1,401,439 5,685,242 7,086,681
North Western 1,651,449 10,296,610 11,948,059
South Eastern 2,831,634 8,780,582 11,612,216
Southern 2,194,649 9,652,590 11,847,239
Western 2,094,637 8,683,971 10,778,608
Research & Education Fund - - 1,503,443
National Savings Distributed 16,949,646 66,197,326 84,650,415
Balance of Savings 
at 31st December 2002 3,370,061 44,907,353 48,711,940
15. Prompt Payment of Accounts Act, 1997 - Statement By Responsible Officer 
The Prompt Payment of Accounts Act, 1997 came into operation on 2nd January 1998. The 
General Medical Services (Payments) Board comes under the remit of the Act. The payment
practices of the Board are reported on below for the year ended 31st December 2002,
in accordance with Section 12 of the Act.
(a) It is the policy of the Board to ensure that all payments are made promptly.
(b) The system of internal control incorporates such procedures as are considered necessary 
to ensure compliance with the Act. The Board’s system of internal control includes accounting
controls designed to ensure identification of contracts and invoices due for payment within 
the prescribed payment dates defined by the Act. These controls are designed to provide
reasonable and not absolute assurance against material non-compliance with the Act.
(c) The total amount of Prompt Payment of Accounts Act interest paid by the Board in 2002 
was €10,675.
16. Basis of Preparation
The Board’s Financial Statements are presented subject to Audit.
The Financial Statements are prepared on the basis of the payment year January to December 
with the inclusion of accruals for both income and expenditure.
The statistical data and associated financial values are prepared on the basis of payments made 
in the 12 months March to February which relates to claims for the calendar year January 
to December, accruals are not provided.


